Valuation Sanofi

Stocks

Real-time Euronext Paris 13:39:22 14/08/2026 BST			5-day change	1st Jan Change
75.62 ^EUR	-1.06%		+0.41%	-8.58%

07:47am	AlphaValue still cautious about Sanofi
08-13	Sanofi: Q2 beat gets sidelined by burning pipeline issues

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	91,568	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-9.03%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	102,984	99,801	96,299
Change	-	-1.71%	1.04%	4.49%	-11.2%	-7.77%	-3.09%	-3.51%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	12.1x	10.6x	9.14x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.24x	1.17x	1.1x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-7.15x	0.7x	0.6x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.92x	1.81x	1.72x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.16x	1.97x	1.81x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.99x	6.37x	5.66x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.77x	7.17x	6.35x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	12.4x	11.1x	9.55x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.09%	9.05%	10.5%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.254	4.499	4.797
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.57%	5.89%	6.28%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.292	7.204	8.361
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	67.6%	62.4%	57.4%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,593	50,704	53,143
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,738	15,679	17,014
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,248	13,921	15,160
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,941	9,267	10,396
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,415	8,233	4,731
Reference price ²	88.58	89.84	89.76	93.74	82.72	76.43	76.43	76.43
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	04/02/22	03/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SANOFI	12.15x	2.16x	6.99x	5.57%	106B
ELI LILLY AND COMPANY	34.32x	12.47x	25.45x	0.57%	1,078B
JOHNSON & JOHNSON	29.15x	-	-	2.05%	632B
ABBVIE INC.	32.02x	7.45x	15.48x	2.73%	443B
ROCHE HOLDING AG	20.19x	4.79x	11.87x	2.76%	356B
NOVARTIS AG	21.62x	5.6x	13.97x	2.87%	289B
ASTRAZENECA PLC	20.24x	4.18x	11.87x	2.1%	245B
AMGEN INC.	26.43x	6.88x	12.21x	2.41%	226B
NOVO NORDISK A/S	13.48x	4.84x	10.07x	3.78%	204B
GILEAD SCIENCES, INC.	-42.9x	6.13x	34.58x	2.39%	171B
Average	16.67x	6.06x	15.83x	2.72%	374.93B
Weighted average by Cap.	24.18x	7.99x	18.26x	2.07%